Growth Metrics

Palisade Bio (PALI) Prepaid Assets (2010 - 2026)

Palisade Bio (PALI) reported Prepaid Assets of $265000.0 for Q1 2026, down 59.67% year-over-year from $657000.0 in Q1 2025, and down 25.35% on a QoQ basis from $355000.0 in Q4 2025.

Palisade Bio (PALI) has 17 years of Prepaid Assets data on file, last reported at $265000.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 59.67% year-over-year to $265000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $265000.0 (down 59.67% YoY) and the FY2025 annual result came in at $355000.0, up 1988.24% from the prior year.
  • Prepaid Assets eased to $265000.0 in Q1 2026 per PALI's latest filing, from $355000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.4 million in Q2 2022 and bottomed at $4000.0 in Q2 2023.
  • The 5-year median for Prepaid Assets is $531000.0 (2025), against an average of $644588.2.
  • The widest annual swing landed in 2023, when Prepaid Assets slumped 99.84%; it then soared 14250.0% in 2024.
  • Tracing PALI's Prepaid Assets over 5 years: stood at $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then jumped by 183.33% to $17000.0 in 2024, then jumped by 1988.24% to $355000.0 in 2025, then decreased by 25.35% to $265000.0 in 2026.
  • Per Business Quant, the three latest PALI Prepaid Assets figures stand at $265000.0 (Q1 2026), $355000.0 (Q4 2025), and $445000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 265,000.00
Dec 31, 2025 355,000.00
Sep 30, 2025 445,000.00
Jun 30, 2025 531,000.00
Mar 31, 2025 657,000.00
Dec 31, 2024 17,000.00
Sep 30, 2024 830,000.00
Jun 30, 2024 574,000.00
Mar 31, 2024 737,000.00
Dec 31, 2023 6,000.00
Sep 30, 2023 954,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 355,000.00
Dec 31, 2022 6,000.00
Sep 30, 2022 1.17 Mn
Jun 30, 2022 2.44 Mn
Mar 31, 2022 1.61 Mn
Dec 31, 2021 540,000.00
Sep 30, 2021 1.99 Mn
Jun 30, 2021 2.01 Mn
Mar 31, 2021 1.31 Mn
Dec 31, 2020 31,000.00
Sep 30, 2020 1.43 Mn
Jun 30, 2020 390,646.00
Mar 31, 2020 414,683.00
Dec 31, 2019 510,900.00
Sep 30, 2019 605,312.00
Jun 30, 2019 256,776.00
Mar 31, 2019 295,406.00
Dec 31, 2018 363,288.00
Sep 30, 2018 545,187.00
Jun 30, 2018 343,428.00
Mar 31, 2018 346,995.00
Dec 31, 2017 402,273.00
Sep 30, 2017 548,766.00
Jun 30, 2017 239,309.00
Mar 31, 2017 477,072.00
Dec 31, 2016 646,195.00
Sep 30, 2016 946,943.00
Jun 30, 2016 705,840.00
Mar 31, 2016 1.08 Mn
Dec 31, 2015 1.16 Mn
Sep 30, 2015 1.29 Mn
Jun 30, 2015 904,222.00
Mar 31, 2015 388,065.00
Dec 31, 2014 274,106.00
Sep 30, 2014 409,140.00
Jun 30, 2014 196,209.00
Mar 31, 2014 319,616.00
Dec 31, 2013 255,733.00
Sep 30, 2013 343,973.00
Jun 30, 2013 156,592.00
Mar 31, 2013 220,914.00
Dec 31, 2012 205,651.00
Sep 30, 2012 289,788.00
Jun 30, 2012 234,188.00
Mar 31, 2012 404,604.00
Dec 31, 2011 430,356.00
Sep 30, 2011 653,854.00
Jun 30, 2011 300,745.00
Dec 31, 2010 246,887.00